Wow this sounds great and really cutting edge. I wonder what the pricing model would look like for the process and would insurance pay for it. How much $$ could you license the process to a doctor for. Is it a yearly subscription, per patient subscription, etc. we are so far ahead of every one in this approach if accepted.
All the companies in the consortium will benefit having this framework in place. I’m guessing they all have their own drugs that they would like to test and validate as well.
Is this consortium Missling’s doing? I’m wondering who led this initiative to begin. Wondering if the members were hand selected or was it open. Interesting.
Market Data 
Markets 
